US/UK/Canada

Share

Contacts

  • Johanna Nilsson

    Head of Marketing


    • Links

    Quotes

    We are thrilled that TATAA Biocenter has expanded its use of digital PCR on the naica system, as customers see the value of Stilla’s powerful, easy-to-use multiplexing technology
    Philippe Mourere, President and CEO, Stilla Technologies
    In heart failure, my area of interest, it is very common that we don’t know for sure how drugs work. Biomarker research, optimally using proteomics, such as research enabled by Olink® EXPLORE 3072, when applied to clinical trial blood samples and with appropriate use of sophisticated data science, may help unravel the mechanisms of action (MOA) of therapies. In the HOMAGE trial, I was amazed by being able to describe the multiple MOAs of the mineralocorticoid receptor antagonist spironolactone, mostly known, so far, only from animal experimental data. Examining the MOAs of drugs in the clinical setting is among the major advances allowed by proteomics
    professor Faiez Zannad, previous head Head of the Centre d’Investigation Clinique Pierre Drouin Inserm, coordinator of the Heart OMics in AGEing (HOMAGE) project
    We are excited to be partnering with TATAA Biocenter. This will make the Olink proteomics platform more accessible to the scientific community, which is in line with our mission of accelerating research in areas such as the understanding of disease, more efficient and safer drug development, and enablement of earlier and more accurate diagnoses
    Henk Mouthaan, Interim Vice President Sales and Marketing EMEA, Olink Proteomics.
    We are excited to recognize and celebrate the companies in this year’s Deloitte Sweden Technology Fast 50. The companies ranked, and the smart solutions and services they provide, reflect Sweden’s position at the forefront of innovation, entrepreneurship and digital transformation. Qualifying for a place on the list is a significant achievement and we look forward to seeing what’s next for these companies
    Ester Sundström, partner and responsible for Deloitte Sweden Technology Fast 50.
    The center ensures that it validates the use of kits and reagents prior to offering services using the vendor's products, Frost & Sullivan research confirms that TATAA Biocenter is the only company that adheres to high quality standards in comparison to its competitors in Europe.
    Divyaa Ravishankar, Frost & Sullivan Senior Research Analyst
    Pick a time period -
    Tags ( Active)

    TATAA Announces Formation of Scientific Advisory Board

    TATAA Biocenter (the “Company” or “TATAA”), a leading global CRO for high-quality molecular analysis, announced the formation of its Scientific Advisory Board (“SAB”). The SAB will advise the Company and its leadership team on strategic matters, research and development initiatives, and other areas where their expertise is beneficial to the growth of TATAA’s services. The inaugural members of the SAB include Dr. Binodh DeSilva, Dr. Kaia Sartori, Dr. Lydia Michaut, Dr. Matthias Machacek, and Dr. Zain Kassam."We are excited to have such a distinguished group of experts on our Scientific

    TATAA Biocenter - the most comprehensive CRO for microRNA analysis

    TATAA Biocenter, a leading CRO of molecular analysis services , announces it has become a certified service provider for RealSeq Biosciences , a developer of innovative sequencing solutions for microRNA analysis.This collaboration will bring considerable benefits to scientific researchers by providing access to a comprehensive range of molecular analysis services, including RealSeq Biosciences’ cutting-edge small RNA sequencing technology. As a service provider for RealSeq Biosciences, TATAA Biocenter will offer a full

    TATAA Biocenter partners with Universal Sequencing Technology Corporation to offer “Linked Long Read” Sequencing Services.

    TATAA Biocenter has partnered with Universal Sequencing Technology Corporation (UST) to offer full-service solutions for Long Read Sequencing Applications using UST TELL-Seq Linked Read technology. TATAA Biocenter was founded in 2001 and is a leading provider of molecular services to the Advanced Therapies and Medical products (ATMP) industries in Europe and to the Cell and Gene Therapy industry in the United States. UST’s TELL-Seq technology, a transposase-based patent-pending linked-read library technology, enables short read 2nd generation NGS platforms, such as Illumina

    TATAA Biocenter goes live with a modern, fully-automated LIMS – a big day for their state-of-the-art laboratory in Gothenburg.

    It’s been over 12 months in the making and TATAA Biocenter has now gone live with its Laboratory Information Management System (LIMS) from Benchling. Integrating processes, samples, instruments, and informatics into one automated and unified platform. Effectively managing sequencing and PCR data can be challenging, with issues in data security and sample management and potential mistakes caused by human error. A modern LIMS solution allows you to connect everything in the laboratory so you can record and trace all that you do to an individual sample. Every process, every

    TATAA Biocenter and pivotal research project will establish Sweden as a major leader in ATMPs

    As part of a 320M SEK investment program in biological therapies, one research project will play a pivotal role in making Sweden a major leader in Advanced Therapeutic Medical Products (ATMPs) by 2030. Huge investments are being made in the development of cell-based therapies, and a new Vinnova  funded project called Transfer learning across technologies for ATMPs (Advanced Therapy Medicinal Products), starting in Gothenburg, Sweden, will spearhead this new and exciting field of drug development. ATMPs are therapies based on biological materials, such

    TATAA Biocenter Expands Digital PCR Service Offering with Stilla’s 6-Color naica® system

    Today TATAA Biocenter, Europe’s leading provider of molecular analysis services, announced it is adding Stilla’s six-color naica® system to its digital PCR service offerings. Leveraging on the powerful multiplexing capabilities of the industry’s first digital PCR system featuring six fluorescent channels, TATAA Biocenter will develop custom assays based on TATAA Biocenter’s proprietary Two-Tailed PCR technology and offer ready-to-use dPCR kits for a variety of applications.TATAA Biocenter has been providing dPCR service since 2008, when the company developed PCR tomography, and researchers

    Tataa Biocenter is partnering with Olink and Illumina to offer high performance proteomics with unprecedented throughput

    Tataa Biocenter AB, a leading European provider of molecular analysis services with ISO 17025 accreditation, is launching Olink® EXPLORE 3072 proteome profiling service. This new platform offers exceedingly high performance with unprecedented throughput based on Illumina sequencing technology.Olink’s technology — Proximity Extension Assay (PEA) — uses pairs of antibodies with DNA tags that prime PCR when bound to the targeted protein. With Olink® EXPLORE 3072, next-generation sequencing is used to quantify each of 3072 protein targets. Tataa Biocenter  has more than

    TATAA Biocenter listed as one of Sweden's fastest growing tech companies

    TATAA Biocenter is listed as one of Sweden's fastest growing tech companies by accounting organization Deloitte. Sweden Technology Fast 50  includes public and private companies in all areas of technology, from software and hardware to life science, communications and clean technology. The ranking is based on the companies average revenue increase during a 4-year period.TATAA Biocenter is listed as one of Sweden's fastest growing tech companies by accounting

    TATAA Biocenter named “Best Nucleic Acid Analysis Service Provider in Europe” by Global Health & Pharma

    Global Health & Pharma, a British information platform supporting a community of over 250,000 in the health, veterinary and environmental areas, has named Swedish service provider TATAA Biocenter AB “Best Nucleic Acid Analysis Service Provider in Europe”.Global Health & Pharma, a British information platform supporting a community of over 250,000 in the health, veterinary and environmental areas, has named Swedish service provider TATAA Biocenter AB “Best Nucleic Acid Analysis Service Provider in Europe”. TATAA Biocenter has developed Two-Tailed PCR technology, which compared to

    TATAA Biocenter and BTU develops Two-tailed PCR for microRNA analysis offering superior sensitivity and specificity.

    TATAA Biocenter and the Institute of Biotechnology, BIOCEV, have developed Two-Tailed PCR for ultrasensitive analysis of microRNAs based on products from Roche. Based on an innovative novel design with a RT primer sensing the microRNA using two connected hemi-probes exceeding sensitivity and superior specificity is achieved. The results of the work appeared in this week’s issue of the prestigious journal Nucleic Acids Research.TATAA Biocenter and the Institute of Biotechnology, BIOCEV, have developed Two-Tailed PCR for ultrasensitive analysis of microRNAs based on products from Roche. Based

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media